Bio-Techne
TECH
#1522
Rank
โ‚น953.66 B
Marketcap
โ‚น6,002
Share price
3.39%
Change (1 day)
13.37%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚น33.69 Billion

According to Bio-Techne's latest financial reports the company's total debt is โ‚น33.69 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-06-30โ‚น37.34 B45.19%
2022-06-30โ‚น25.71 B-17.68%
2021-06-30โ‚น31.24 B-4.8%
2020-06-30โ‚น32.81 B-5.78%
2019-06-30โ‚น34.83 B50.11%
2018-06-30โ‚น23.20 B4.18%
2017-06-30โ‚น22.27 B246.8%
2016-06-30โ‚น6.42 B30.84%
2015-06-30โ‚น4.90 B531.49%
2014-06-30โ‚น0.77 B
2006-06-30โ‚น0.61 B-3.18%
2005-06-30โ‚น0.63 B-12.7%
2004-06-30โ‚น0.72 B-8.13%
2003-06-30โ‚น0.79 B-10.23%
2002-06-30โ‚น0.88 B-0.9%
2001-06-30โ‚น0.89 B1.03%
2000-06-30โ‚น0.88 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚น2.983 T 8,752.20%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น117.26 B 247.97%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.632 T 4,743.85%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.480 T 4,292.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น118.40 B 251.36%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚น1.682 T 4,894.01%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.29 B-99.12%๐Ÿ‡บ๐Ÿ‡ธ USA